✦ LIBER ✦

Treatment of acute non-A, non-B hepatitis with interferon alpha-2b

✍ Scribed by N. C. Tassopoulos; Maria Koutelou; G. Papatheodoridis; Th. Giannikakis; Melpomeni Paraloglou-Ioannides; Helen Polychronaki; A. Hatzakis

Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 192 KB
Volume: 20
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf02033074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with interferon

✍ Karino, Yoshiyasu ;Matsushima, Takashi ;Saga, Akiyoshi ;Tsuyuguchi, Masako ;Miya 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 407 KB

Interferon therapy for non-A, non-B chro

Interferon therapy for non-A, non-B chronic hepatitis

✍ Lino, Shiro ;Hino, Kunihiko ;Kondo, Toshiro ;Koike, Kazuhiko ;Yasuda, Kiyomi ;Yo 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 533 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

Acute sporadic non-A, non-B hepatitis in

Acute sporadic non-A, non-B hepatitis in Greece

✍ Nicolaos C. Tassopoulos; Michael Alikiotis; Fragiscos Limotirakis; Panayiotis Ni 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

The influence of non-A, non-B (NANB) agent(s) on the aetiology of acute sporadic viral hepatitis and its possible transition to chronic hepatitis were studied. Acute sporadic NANB hepatitis was diagnosed in 134 (13.5%) of the 993 Greek adults who were admitted consecutively to the Western Attica Gen

Non-A, non-b hepatitis in chimpanzees: I

Non-A, non-b hepatitis in chimpanzees: Interference with acute hepatitis A virus and chronic hepatitis B virus infections

✍ Dr. Daniel W. Bradley; James E. Maynard; Karen A. McCaustland; Bert L. Murphy; E 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

Two chimpanzees with persistent non-A, non-B (NANB) hepatitis were superinfected with marmoset-passaged MS-1 HAV. Two control chimpanzees were also infected with marmoset-passaged HAV. Neither animal with persistent NANB hepatitis developed elevated alanine aminotransferase (ALT) activity, whereas b

Treatment with human gamma interferon of

Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon

✍ Shinichi Kakumu; Tetsuya Ishikawa; Masashi Mizokanii; Etsuro Orido; Kentaro Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract A pilot study was designed to determine the tolerance and effectiveness of natural or recombinant gamma interferon in patients with chronic hepatitis B. Sixteen patients received 0.5 to 3.0 million units (MU) per day of gamma interferon (IFN‐γ) for 7 days. Nineteen chronic hepatitis B p